RESUMEN
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief and Deputy Editor-in-Chief following an investigation into the data that were presented in several figures within the article. A number of images used in this article are believed to be duplicated images. The authors stated that they inadvertently inserted images of the wrong blots in several of the figures, resulting in the duplications; however, they did not address all of the concerns raised. Because the editors were no longer confident in the conclusions of the article based on these incorrect data, a decision was made to retract the paper. All authors have been notified of this decision. The University of Campinas (UNICAMP) in São Paulo, Brazil was contacted regarding these concerns, but to date the journal has received no response.
RESUMEN
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and Deputy Editor-in-Chief following an investigation into the data that were presented in several figures within the article. A number of images used in this article are believed to be duplicated images. The authors stated that they inadvertently inserted images of the wrong blots in several of the figures, resulting in the duplications; however, they did not address all of the concerns raised. Because the editors were no longer confident in the conclusions of the article based on these incorrect data, a decision was made to retract the paper. All authors have been notified of this decision. The University of Campinas (UNICAMP) in São Paulo, Brazil was contacted regarding these concerns, but to date the journal has received no response.
Asunto(s)
Colitis/etiología , Colon/inmunología , Neoplasias del Colon/etiología , Mediadores de Inflamación/metabolismo , Obesidad/complicaciones , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Anticuerpos Monoclonales/farmacología , Antineoplásicos/farmacología , Apoptosis , Azoximetano , Western Blotting , Proliferación Celular , Colitis/genética , Colitis/inmunología , Colitis/metabolismo , Colitis/patología , Colitis/prevención & control , Colon/efectos de los fármacos , Colon/metabolismo , Neoplasias del Colon/genética , Neoplasias del Colon/inmunología , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Neoplasias del Colon/prevención & control , Sulfato de Dextran , Modelos Animales de Enfermedad , Activación Enzimática , Células HT29 , Humanos , Hiperinsulinismo/tratamiento farmacológico , Hiperinsulinismo/etiología , Hiperinsulinismo/metabolismo , Hipoglucemiantes/farmacología , Quinasa I-kappa B/metabolismo , Inmunohistoquímica , Mediadores de Inflamación/antagonistas & inhibidores , Infliximab , Insulina/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones SCID , Obesidad/genética , Obesidad/inmunología , Obesidad/metabolismo , Fosfatidilinositol 3-Quinasa , Pioglitazona , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal , Serina-Treonina Quinasas TOR/metabolismo , Tiazolidinedionas/farmacología , Factores de Tiempo , Carga Tumoral , Factor de Necrosis Tumoral alfa/antagonistas & inhibidoresRESUMEN
BACKGROUND: Measurements of CFTR function in rectal biopsies ex vivo have been used for diagnosis and prognosis of Cystic Fibrosis (CF) disease. Here, we aimed to evaluate this procedure regarding: i) viability of the rectal specimens obtained by biopsy forceps for ex vivo bioelectrical and biochemical laboratory analyses; and ii) overall assessment (comfort, invasiveness, pain, sedation requirement, etc.) of the rectal forceps biopsy procedure from the patients perspective to assess its feasibility as an outcome measure in clinical trials. METHODS: We compared three bowel preparation solutions (NaCl 0.9%, glycerol 12%, mannitol), and two biopsy forceps (standard and jumbo) in 580 rectal specimens from 132 individuals (CF and non-CF). Assessment of the overall rectal biopsy procedure (obtained by biopsy forceps) by patients was carried out by telephone surveys to 75 individuals who underwent the sigmoidoscopy procedure. RESULTS: Integrity and friability of the tissue specimens correlate with their transepithelial resistance (r = -0.438 and -0.305, respectively) and are influenced by the bowel preparation solution and biopsy forceps used, being NaCl and jumbo forceps the most compatible methods with the electrophysiological analysis. The great majority of the individuals (76%) did not report major discomfort due to the short procedure time (max 15 min) and considered it relatively painless (79%). Importantly, most (88%) accept repeating it at least for one more time and 53% for more than 4 times. CONCLUSIONS: Obtaining rectal biopsies with a flexible endoscope and jumbo forceps after bowel preparation with NaCl solution is a safe procedure that can be adopted for both adults and children of any age, yielding viable specimens for CFTR bioelectrical/biochemical analyses. The procedure is well tolerated by patients, demonstrating its feasibility as an outcome measure in clinical trials.
Asunto(s)
Biopsia/instrumentación , Biopsia/métodos , Fibrosis Quística/patología , Satisfacción del Paciente , Recto/patología , Adulto , Anestésicos Intravenosos/administración & dosificación , Biopsia/efectos adversos , Western Blotting , Catárticos , Niño , Regulador de Conductancia de Transmembrana de Fibrosis Quística/análisis , Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Técnica del Anticuerpo Fluorescente , Glicerol , Humanos , Manitol , Mutación , Dolor/etiología , Pronóstico , Cloruro de Sodio , Instrumentos Quirúrgicos , Encuestas y CuestionariosRESUMEN
Gastrointestinal (GI) acute graft-versus-host disease (aGVHD) remains one of the most important complications of allogeneic hematopoietic cell transplantation (allo-HCT). The diagnosis of this complication is largely dependent on clinical symptoms, but GI biopsies are warranted in most cases, due to the multitude of potential causes that coexist in patients with a clinical suspicion of this complication. In addition, several lines of evidence support that the GI is not only a target organ in aGVHD, but also a key mediator of the pathogenesis of this condition. Controversy exists on whether histopathological findings are associated with clinical severity. Crypt loss is a relatively straightforward histological finding of GI aGVHD, whose presence has been associated with disease severity in a previous study.In order to independently validate this association, we retrospectively evaluated all histological changes from 25 patients with confirmed GI aGVHD who underwent allo-HCT in our center from 2008 to 2014. Clinical, laboratory, and histological data were obtained from the medical records and pathological reports. All GI biopsies were reviewed by 2 investigators blinded to clinical data, who classified GI aGVHD according to the presence of severe crypt loss.The proportion of patients with grades I-II and III-IV aGVHD patients in our population were 45.5% and 54.5%, respectively. The most common histological alterations were isolated apoptotic bodies, present in 80% of colon biopsies with aGVHD. Severe crypt loss, corresponding to grades III-IV aGVHD was associated with higher stool volumes (Pâ=â.02) and increased diarrhea duration (Pâ=â.02), but not with response to steroids or mortality.In this study, we independently validated that the presence of severe crypt loss, a reliable and simple parameter to grade the extension of GI aGVHD, is associated with disease severity in GI aGVHD.
Asunto(s)
Diarrea , Tracto Gastrointestinal/patología , Enfermedad Injerto contra Huésped , Trasplante de Células Madre Hematopoyéticas , Biopsia/métodos , Brasil , Diarrea/diagnóstico , Diarrea/etiología , Diarrea/patología , Femenino , Enfermedad Injerto contra Huésped/diagnóstico , Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/patología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/métodos , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Estadística como Asunto , Trasplante Homólogo/efectos adversos , Trasplante Homólogo/métodosRESUMEN
BACKGROUND: Serrated colorectal lesions are increasingly recognized as an important process in the development of colorectal cancer. Endoscopic and histological diagnosis may be difficult, and knowledge of the serrated lesions is important for the establishment of strategies for treating colorectal lesions. We aimed to analyze serrated lesions diagnosed at a single center and evaluate if there was an increase in their identification over the years. DESIGN AND SETTING: A retrospective analysis of colonoscopy reports was performed at a specialized center from 2005 to 2014. METHODS: Colonoscopy reports about any resected endoscopic lesions were reviewed and subjected to histological diagnosis from 2005 to 2014. Then, serrated lesions were evaluated based on morphological characterization, location, size, occurrence of synchronous lesions, and the patient's history of colorectal cancer and polyps. RESULTS: A total of 2126 colonoscopy examination reports were reviewed, and 3494 lesions were analyzed. On histopathological examination, 1089 (31.2%) were classified as hyperplastic polyps, 22 (0.6%) as sessile serrated adenomas, and 21 (0.6%) as traditional serrated adenomas. There was an increase in the number of cases of sessile and traditional serrated adenomas diagnosed after 2010. Before 2010, two cases of sessile serrated adenomas and seven cases of traditional serrated adenomas were diagnosed; after 2010, 20 cases of sessile serrated adenoma and 14 cases of traditional serrated adenomas were diagnosed. CONCLUSION: There was an increase in the diagnosis of sessile serrated adenomas over the years, which can be attributed to better accuracy in colonoscopy and histological classification.
RESUMEN
Chondromatous hamartoma of the chest wall is an extremely rare, benign lesion that usually occurs in early infancy. It typically arises in the rib cage and produces a large mass. It is composed of a varying admixture of hyaline cartilage that has features resembling growth plate cartilage, fascicles of spindle cells, woven bone, and hemorrhagic cysts. Treatment consists mainly of surgical excision, which is usually curative. We present 3 new cases, which demonstrated interesting findings, including multicentricity, involvement of the sternum, and local recurrence, and we discuss these findings in the context of a literature review.
Asunto(s)
Enfermedades de los Cartílagos/patología , Hamartoma/patología , Pared Torácica/patología , Enfermedades de los Cartílagos/cirugía , Niño , Condroma/patología , Diagnóstico Diferencial , Femenino , Hamartoma/cirugía , Humanos , Cartílago Hialino/patología , Cartílago Hialino/cirugía , Inmunohistoquímica , Lactante , Masculino , Costillas/patología , Pared Torácica/cirugíaRESUMEN
Objetivo: Descrever um caso de hemangioendotelioma kaposiforme, único tumor malígno de origem vascular específico da infância. Métodos: Relata-se o caso de lactente do sexo feminino com 40 dias de vida que apresentava um hemagioma gigante da face. O tumor evoluiu com crescimento rápido levando à compressäo da laringe com insuficiência grave. A criança tinha ainda uma coagulopatia trombocitopênica de consumo (síndrome de Kasabach-Merritt). Resultados: Ela foi admitica à UTI Pediátrica do Hospital das Clínicas da Universidade Estadual de Campinas e foi iniciada ventilaçäo mecânica. O tratamento durante dez dias com dexametasona levou à melhora por curto período. Foi inciado interferon alfa-2a na dose de 1,8 milhöes de unidades/m²/dia por via subcutânea, porém a paciente foi à óbito 4 dias após o início dessa terapia. A necrópcia revelou o diagnóstico de um hemangioendotelioma kapasiforme. Conclusäo: Discutem-se a evoluçäo fatal pouco freqüente de um hemangioma gigante e suas complicaçöes hematológicas.